Novo Nordisk's stock plummets over 13% after the company warns of potential sales and profit declines in 2026, facing increasing competition in the weight-loss market, particularly from Eli Lilly's ...
Eli Manning was drafted by the Chargers but never played a game for the club.
Eli Lilly is the leader in GLP-1 weight loss drugs today, but that advantage won't last forever.